NCT03130491View on ClinicalTrials.gov

European Study Evaluating the EMBLOK Embolic Protection System During TAVR

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

November 1, 2021

Study Completion Date

January 28, 2022

Conditions
Aortic Valve Disease
Interventions
PROCEDURE

Transcatheter Aortic Valve Replacement (TAVR)

placement of a filter to capture and remove embolic material from entering the cerebral vascular circulation during aortic valve replacement

DEVICE

EMBLOK filter

Embolic Filter Protection System During TAVR

Trial Locations (2)

20097

Hospital San Donato, Milan

20132

Hospital San Raffaele, Milan

All Listed Sponsors
collaborator

Meditrial Europe Ltd.

INDUSTRY

lead

Emblok, Inc.

INDUSTRY

NCT03130491 - European Study Evaluating the EMBLOK Embolic Protection System During TAVR | Biotech Hunter | Biotech Hunter